Publications by authors named "C R Rhoden"

Melanoma is the most aggressive type of skin cancer, with few therapeutic alternatives following metastasis development. In recent years, drug delivery-associated nanotechnology has shown promising targeted results with diminished adverse effects compared to conventional treatments. This study aimed to (1) examine the effects of plant-derived α-arbutin, a natural compound and (2) compare these findings with bioactively developed liposomes containing α-arbutin utilizing the B16-F10 murine melanoma cell line as a model.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the effective adsorption of the pesticide acephate using chitosan modified with varying amounts of magnetite through a simple co-precipitation method.
  • The best results were achieved with a 1:1 chitosan to iron oxide ratio, achieving a 74.96% removal rate at pH 9.
  • The process parameters such as pH, adsorbent dosage, and initial concentration significantly influenced the effectiveness, and the adsorption was confirmed to be exothermic and primarily chemical in nature, with high stability over multiple cycles.
View Article and Find Full Text PDF

2,4-Dichlorophenoxyacetic acid (2,4-D) is an herbicide and is among the most widely distributed pollutant in the environment and wastewater. Herein is presented a complete comparison of adsorption performance between two different magnetic carbon nanomaterials: graphene oxide (GO) and its reduced form (rGO). Magnetic functionalization was performed employing a coprecipitation method, using only one source of Fe, requiring low energy, and potentially allowing the control of the amount of incorporated magnetite.

View Article and Find Full Text PDF

Renal neoplasms are highlighted as one of the 10 most common types of cancer. Renal cell carcinoma (RCC) is the most common type of renal cancer, considered the seventh most common type of cancer in the Western world. The most frequently altered genes described as altered are VHL, PBRM1, SETD2, KDM5C, PTEN, BAP1, mTOR, TP53, TCEB1 (ELOC), SMARCA4, ARID1A, and PIK3CA.

View Article and Find Full Text PDF